Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics Previous close 259.78
Open 0.00
Day range 0.00 260.67
52-week range 0.00 409.90
Off day high 0.00%
Off 52-week high −36.41%
Volume 0.00
Avg. volume (3M) 1.00M
Market cap 1.09T
EPS (TTM) 14.86
Forward P/E —
P/E ratio (TTM) 17.54
Dividend yield 1.04% (7.08)
Beta (5Y) —
Shares outstanding 3.40B
Short interest —
Earnings date Nov 4, 2026
Analyst target —
Profit margin —
No recent coverage in the 4Search index.
From articles in the 4Search news index.
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
From Wikipedia , CC BY-SA 4.0
Earnings
Next report: Wed, Nov 4, 2026
Not eligible for Gainers, Losers, Most active (U.S. stocks worth $2 billion or more only).
Not eligible for Small-cap gainers, Aggressive small caps (U.S. stocks worth under $2 billion only).
Not eligible for Growth tech (U.S. technology stocks only).
Not eligible for Undervalued large caps (U.S. stocks worth $10 billion or more only).
A day counts when it ranked in the top 25 of a list. Tracked since Oct 10, 2026.
Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use .